Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 25/05/05

Trade details

Type
Insider sale
Amount
$37,279.55
Shares · price
1,771 sh · $21.05 a share
Held after
128,215 sh
Trade date
25/05/05
Filed
25/05/05
Days to filing
0 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/05~25/06/04

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05